These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

965 related items for PubMed ID: 11051136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States.
    Gupta AK, Joseph WS.
    J Am Podiatr Med Assoc; 2000; 90(10):495-501. PubMed ID: 11107710
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Topical and device-based treatments for fungal infections of the toenails.
    Foley K, Gupta AK, Versteeg S, Mays R, Villanueva E, John D.
    Cochrane Database Syst Rev; 2020 Jan 16; 1(1):CD012093. PubMed ID: 31978269
    [Abstract] [Full Text] [Related]

  • 5. Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study.
    Brenner MA, Harkless LB, Mendicino RW, Page JC.
    J Am Podiatr Med Assoc; 2007 Jan 16; 97(3):195-202. PubMed ID: 17507527
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.
    Zalacain-Vicuña AJ, Nieto C, Picas J, Martínez H, Bermejo R, Corrales A, Campos FF, Igea SA, Otero-Espinar FJ, Briones VG.
    Mycoses; 2023 Jul 16; 66(7):566-575. PubMed ID: 36336989
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes.
    Seebacher C, Nietsch KH, Ulbricht HM.
    Cutis; 2001 Aug 16; 68(2 Suppl):17-22. PubMed ID: 11665724
    [Abstract] [Full Text] [Related]

  • 12. Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes.
    Schalka S, Nunes S, Gomes Neto A.
    An Bras Dermatol; 2012 Aug 16; 87(1):19-25. PubMed ID: 22481647
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M, Sigurgeirsson B, Sarkany M.
    Mycoses; 2017 Dec 16; 60(12):800-807. PubMed ID: 28925059
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ciclopirox nail lacquer topical solution 8%.
    Gupta AK.
    Skin Therapy Lett; 2000 Dec 16; 6(1):1-5. PubMed ID: 11027420
    [Abstract] [Full Text] [Related]

  • 20. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT.
    J Am Acad Dermatol; 2013 Apr 16; 68(4):600-608. PubMed ID: 23177180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.